- Inactivated Vaccine
- Attenuated Live Vaccine
- DNA Vaccine
- Others
Aquaculture Vaccines Market size valued USD 371.8 million in 2020 and is expected to grow at a CAGR of 9.4% CAGR during the forecast period 2021-2027. Aquaculture is the activity of raising aquatic animals for human consumption, and maintaining a healthy livestock population is critical. Because of the rising occurrence of diseases in aquatic animals and the expanding aquaculture industry, the aquaculture vaccines market is predicted to rise rapidly. owing to an increase in R&D for the innovative vaccines by the market players. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the global market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). For instance, in February 2018, In April 2016, Pharma and Zoetis introduced an innovative vaccine ALPHA JECT LiVac SRS that helps control Salmon Rickettsial Septicaemia (SRS) Syndrome. Moreover, an increase in the production of aquaculture species in Norway, Chile, and the USA, a rise in demand for quality meat products, government support for aquaculture farming, and an increase in the prevalence of various aquaculture diseases are anticipated to propel the market over the forecast timeframe. For instance, in October 2017, approximately 125,000 salmon have died due to a disease outbreak at two fish farms on the Isle of Lewis due to the bacterium Pasturella Skyensis infection. However, stringent regulations for approval, a limited number of existed vaccines, and complexity in the storage of vaccines have hampered the revenue of the aquaculture vaccines market.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Increase in the prevalence of various aquaculture diseases is a key factor surge the growth of revenue of market over the forecast years. Water contamination due to residential and industrial wastage enhance the risk for aquaculture diseases which leads to surge in the adoption of vaccines by the famers. For instance, KV3 vaccine administration is increasing in China for carp species due to rise in Koi Herpes virus Disease, a viral disease of common carp Cyprinus carpio, including all its ornamental varieties such as koi, ghost koi etc. In addition, use of antibiotics in certain countries may enhance the adoption of vaccine over the forecast years. For instance, in 2017, The Marine Products Export Development Authority (MPEDA) has released a list of 20 antibiotics and pharmacologically active substances banned for use in aquaculture in India.
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.